Figures & data
Figure 1 Flowchart of study profile.
![Figure 1 Flowchart of study profile.](/cms/asset/7b1ee41a-9fd1-4bdc-9ec1-bcfce1e6dd0c/dcop_a_115137_f0001_c.jpg)
Table 1 Demographic and clinical characteristics of the patients who did and did not develop CAP during follow-up after stratification based on the presence of comorbid CVD
Table 2 Factors associated with CAP occurrence during follow-up after stratification based on the presence of comorbid CVD
Figure 2 Kaplan–Meier curve for pneumonia-free survival of COPD patients stratified by comorbid CVD and ICS-containing therapy (N=2,440).
Abbreviations: CVD, cardiovascular disease; HR, hazard ratio; ICS, inhaled corticosteroid.
![Figure 2 Kaplan–Meier curve for pneumonia-free survival of COPD patients stratified by comorbid CVD and ICS-containing therapy (N=2,440).](/cms/asset/649edd9f-8f25-45b3-b161-37c41ce06cb1/dcop_a_115137_f0002_b.jpg)